electroCore ECOR
NASDAQ ECOR
$9.19 +0.20 (+2.22%)
At close: Sep 10, 2026 · 4:00 PM EDT

electroCore (ECOR) Total Debt (2017 - 2026)

electroCore (ECOR) posted Total Debt of $7.8 million for Q2 2026, up 11.98% on a QoQ basis from $6.9 million in Q1 2026.

Analysis

electroCore (ECOR) Total Debt (2017 - 2026) Analysis & Trends

electroCore has reported Total Debt for 6 years, with the latest figure at $7.8 million in Q2 2026.

  • On a quarterly basis, Total Debt changed N/A year-over-year to $7.8 million in Q2 2026; TTM through Jun 2026 was $7.8 million, a N/A change from a year earlier, with the FY2025 full-year figure at $6.6 million, changed N/A from the prior year.
  • Total Debt was $7.8 million for Q2 2026 at electroCore, up from $6.9 million in the prior quarter.
  • The five-year high for Total Debt was $7.8 million in Q2 2026, with the low at $6.5 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn 32.61 Bn
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn -
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn 28.15 Bn
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn 14.94 Bn
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn 12.62 Bn
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn 598.70 Mn
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn 4.15 Bn
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn -
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn 2.14 Bn
10 electroCore 87.36 Mn 77.32 Mn 8.18 Mn 7.77 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.77 Mn
Mar 31, 2026 6.94 Mn
Dec 31, 2025 6.61 Mn
Sep 30, 2025 6.53 Mn
Mar 31, 2021 1.41 Mn
Dec 31, 2020 1.41 Mn
Sep 30, 2020 2.06 Mn
Jun 30, 2020 1.41 Mn
Dec 31, 2019 111,878.00
Sep 30, 2019 461,341.00
Dec 31, 2017 2.24 Mn